- Home
- ACR vs OTLK Comparison
ACR vs OTLK Comparison
Compare ACR & OTLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACR
- OTLK
- Stock Information
- Founded
- ACR 2005
- OTLK 2010
- Country
- ACR United States
- OTLK United States
- Employees
- ACR N/A
- OTLK N/A
- Industry
- ACR Real Estate Investment Trusts
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ACR Real Estate
- OTLK Health Care
- Exchange
- ACR Nasdaq
- OTLK Nasdaq
- Market Cap
- ACR 127.9M
- OTLK 121.8M
- IPO Year
- ACR N/A
- OTLK 2016
- Fundamental
- Price
- ACR $16.78
- OTLK $5.41
- Analyst Decision
- ACR Buy
- OTLK Strong Buy
- Analyst Count
- ACR 2
- OTLK 7
- Target Price
- ACR $17.50
- OTLK $48.20
- AVG Volume (30 Days)
- ACR 23.4K
- OTLK 280.9K
- Earning Date
- ACR 10-30-2024
- OTLK 12-20-2024
- Dividend Yield
- ACR N/A
- OTLK N/A
- EPS Growth
- ACR N/A
- OTLK N/A
- EPS
- ACR 0.83
- OTLK N/A
- Revenue
- ACR $77,437,000.00
- OTLK N/A
- Revenue This Year
- ACR N/A
- OTLK N/A
- Revenue Next Year
- ACR N/A
- OTLK N/A
- P/E Ratio
- ACR $20.12
- OTLK N/A
- Revenue Growth
- ACR 8.77
- OTLK N/A
- 52 Week Low
- ACR $7.31
- OTLK $4.61
- 52 Week High
- ACR $16.93
- OTLK $12.85
- Technical
- Relative Strength Index (RSI)
- ACR 69.69
- OTLK 40.47
- Support Level
- ACR $16.00
- OTLK $6.17
- Resistance Level
- ACR $16.93
- OTLK $6.61
- Average True Range (ATR)
- ACR 0.33
- OTLK 0.36
- MACD
- ACR 0.11
- OTLK -0.05
- Stochastic Oscillator
- ACR 92.72
- OTLK 10.80
About ACR ACRES Commercial Realty Corp.
ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.